IBS Co., Ltd.
↗Suwon, South Korea
IBS Co., Ltd. is a premier GMP (Good Manufacturing Practice) consulting and validation service provider based in South Korea. Established in 1997, it holds the distinction of being the first GMP consulting firm in the country. The company specializes in providing comprehensive technical services to the pharmaceutical, biotechnology, and medical device industries, with a particular focus on biological products and injectables.
Their service portfolio includes Computer System Validation (CSV), equipment and facility qualification (IQ/OQ/PQ), conceptual and basic process design, and the development of maintenance programs. IBS also provides mock audit services to help clients prepare for inspections by global regulatory bodies such as the US FDA, EMA, and the South Korean MFDS. They are a key partner for major Korean biopharma companies seeking to align their manufacturing standards with international requirements.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$50M (estimate)
Founded:1997
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, mAb, Cell therapy, Gene therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Samsung Biologics (Likely Client/Partner), Celltrion (Likely Client/Partner), SK Bioscience (Likely Client/Partner)
COMPETITION
Position:Leader
Competitors:Parexel, IQVIA (Regulatory & Compliance division), K-Bio (Korea Bio-information Center), Domestic Korean GMP firms
LEADERSHIP
Key Executives:
Ahn Do-young (안도영) - CEO
Scientific Founders:Ahn Do-young
LINKS
Website:validation.co.kr
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with IBS Co., Ltd.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.